Key points are not available for this paper at this time.
Click to increase image sizeClick to decrease image size FundingThis work was supported in part by NIH K23DC011279 (F. Lin), the Eleanor Schwartz Charitable Foundation (F. Lin), a Triological Society/American College of Surgeons Clinician Scientist Award (F. Lin), and NIA P50-AG005146 (M. Albert).DisclosuresDr Lin reports being on the scientific advisory board of Pfizer and Autifony Therapeutics, a consultant to Cochlear Ltd, and a speaker for Med El and Amplifon. Dr Albert reports being a consultant to Agenebio, Genentech, Eisai and Eli Lilly.
Lin et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: